Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 3/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.43 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.43 |
| ▸ | PPARG | P37231 | 3/20 | 0.42 |
| ▸ | PPARD | Q03181 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 1/20 | 0.42 |
| ▸ | CXCL8 | P10145 | 2/20 | 0.41 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.41 |
| ▸ | FDFT1 | P37268 | 2/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6289845 | 0.83 | CYP1A2 (0.50) | LTA4H | |
| SCHEMBL6289339 | 0.83 | LPAR1 (0.40) | HTR2ASLC6A4LPAR1LPAR5PARP10 | |
| SCHEMBL11735879 | 0.77 | LTA4H (0.45) | HTR2ASLC6A4LTA4H | |
| SCHEMBL6290666 | 0.75 | CXCL8 (0.46) | HTR2ASLC6A4LPAR1LPAR5CXCL8 | |
| SCHEMBL15177168 | 0.74 | LPAR1 (0.51) | LPAR1LPAR5PARP10 | |
| SCHEMBL6186762 | 0.74 | HRH1 (0.62) | HTR2ASLC6A4LTA4H | |
| SCHEMBL29580562 | 0.74 | HRH1 (0.62) | HTR2ASLC6A4LTA4H | |
| SCHEMBL10106200 | 0.74 | FDFT1 (0.53) | PPARGPPARDPPARAFDFT1LTA4H | |
| SCHEMBL6290500 | 0.73 | PARP10 (0.54) | HTR2ASLC6A4LPAR1LPAR5PARP10 | |
| SCHEMBL10106199 | 0.73 | FDFT1 (0.56) | LPAR1LPAR5PPARGPPARAFDFT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6933411-B2 | Aromatic diamine and polyimide thereof | MITSUI CHEMICALS, INC. (JP) | 2005-08-23 | — | — | US | disclosed |
| US-6737503-B2 | LOW TEMPERATURE ADHESIVE BONDING | MITSUI CHEMICALS, INC. (JP) | 2004-05-18 | — | — | US | disclosed |
| US-20040082754-A1 | Novel aromatic diamine and polyimide thereof | MITSUI CHEMICALS, INC. (JP) | 2004-04-29 | — | — | US | disclosed |
| US-20030092870-A1 | Novel aromatic diamine and polyimide thereof | MITSUI CHEMICALS, INC. (JP) | 2003-05-15 | — | — | US | disclosed |
| EP-1288191-A2 | Novel aromatic diamine and polyimide thereof | Mitsui Chemicals, Inc. (JP) | 2003-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030092870-A1 | Novel aromatic diamine and polyimide thereof | DDT, AOC1, H1-4 | HTR2A 3542/4885SLC6A4 1103/4885LPAR1 3847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.